{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:23:22Z","timestamp":1788888202399,"version":"build-2803163510"},"reference-count":36,"publisher":"American Association for Cancer Research (AACR)","issue":"12","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Arginine deprivation using arginase emerges as a potential cancer treatment approach, as some cancers have been found to be arginine-auxotrophic, relying on exogenous arginine for their growth. In this study, we evaluated the combination of a PEGylated recombinant human arginase (PEG-BCT-100), which is currently undergoing clinical trials, with a toxic arginine analog, canavanine, in pancreatic cancer. Remarkable synergistic antitumor effect was observed both in vitro and in vivo. Specifically, the combination treatment induced apoptotic cell death in pancreatic cancer cells, whereas normal fibroblast cells remained viable. Our findings also suggested that pancreatic tumors lacking the key enzymes in arginine biosynthesis, argininosuccinate synthetase 1 (ASS1) and ornithine transcarbamylase (OTC), were more susceptible to the treatment. From our in-house cohort and online database analysis, we found that the majority of the patients with pancreatic cancer exhibited deficiencies in both ASS1 and OTC enzymes, suggesting that the combination of arginine deprivation and canavanine could be particularly effective in these patients. The ASS1 and OTC negativity could also serve as predictive biomarkers for the response in other arginine-dependent cancers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This study investigates the synergistic antitumor effect of PEG-BCT-100, an arginase, in clinical trials, with canavanine in pancreatic cancer, in vitro and in vivo. The treatment induces cancer cell apoptosis while sparing normal fibroblasts. Our findings suggest heightened susceptibility of pancreatic tumors deficient in arginine biosynthesis enzymes ASS1 and OTC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-24-0425","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T08:48:38Z","timestamp":1732178918000},"page":"3180-3189","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["PEG-BCT-100 and Canavanine Synergistically Induce Apoptosis in Arginine Biosynthetic Enzyme-Deficient Pancreatic Cancer"],"prefix":"10.1158","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1870-1046","authenticated-orcid":false,"given":"Tsz Tung","family":"Kwong","sequence":"first","affiliation":[{"name":"1Department of Clinical Oncology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1133-1124","authenticated-orcid":false,"given":"Hao Hao","family":"Deng","sequence":"additional","affiliation":[{"name":"1Department of Clinical Oncology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4157-6287","authenticated-orcid":false,"given":"Chi-Hang","family":"Wong","sequence":"additional","affiliation":[{"name":"1Department of Clinical Oncology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1771-163X","authenticated-orcid":false,"given":"Anthony W.H.","family":"Chan","sequence":"additional","affiliation":[{"name":"2Department of Anatomical and Cellular Pathology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1306-5896","authenticated-orcid":false,"given":"Landon Long","family":"Chan","sequence":"additional","affiliation":[{"name":"1Department of Clinical Oncology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7921-3807","authenticated-orcid":false,"given":"Siu-Ho K.","family":"Chok","sequence":"additional","affiliation":[{"name":"3Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7492-9201","authenticated-orcid":false,"given":"Paul N.","family":"Cheng","sequence":"additional","affiliation":[{"name":"4BioCancer Treatment International Ltd, Hong Kong SAR, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8998-5480","authenticated-orcid":false,"given":"Stephen","family":"Chan","sequence":"additional","affiliation":[{"name":"1Department of Clinical Oncology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"2025051308465598500_bib1","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"2025051308465598500_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"2025051308465598500_bib3","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMra1404198","article-title":"Pancreatic adenocarcinoma","volume":"371","author":"Ryan","year":"2014","journal-title":"N Engl J Med"},{"key":"2025051308465598500_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/14737140.2018.1403319","article-title":"Recent advances in the management of pancreatic adenocarcinoma","volume":"18","author":"Karakas","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"2025051308465598500_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s11864-021-00895-4","article-title":"Systemic therapy for metastatic pancreatic cancer","volume":"22","author":"Ettrich","year":"2021","journal-title":"Curr Treat Options Oncol"},{"issue":"6 Suppl 2","key":"2025051308465598500_bib6","doi-asserted-by":"crossref","first-page":"1602S","DOI":"10.1093\/jn\/137.6.1602S","article-title":"Arginine metabolism: boundaries of our knowledge","volume":"137","author":"Morris","year":"2007","journal-title":"J Nutr"},{"key":"2025051308465598500_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mc.20168","article-title":"The role of NO synthases in arginine-dependent small intestinal and colonic carcinogenesis","volume":"45","author":"Yerushalmi","year":"2006","journal-title":"Mol Carcinog"},{"key":"2025051308465598500_bib8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ijc.30051","article-title":"Molecular basis and current strategies of therapeutic arginine depletion for cancer","volume":"139","author":"Fultang","year":"2016","journal-title":"Int J Cancer"},{"key":"2025051308465598500_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1158\/0008-5472.CAN-06-1945","article-title":"Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion","volume":"67","author":"Cheng","year":"2007","journal-title":"Cancer Res"},{"key":"2025051308465598500_bib10","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s10637-021-01111-8","article-title":"A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma","volume":"39","author":"Chan","year":"2021","journal-title":"Invest New Drugs"},{"key":"2025051308465598500_bib11","first-page":"5443","article-title":"Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo","volume":"62","author":"Ensor","year":"2002","journal-title":"Cancer Res"},{"key":"2025051308465598500_bib12","doi-asserted-by":"crossref","first-page":"7126","DOI":"10.1158\/1078-0432.CCR-06-1101","article-title":"In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion","volume":"12","author":"Szlosarek","year":"2006","journal-title":"Clin Cancer Res"},{"key":"2025051308465598500_bib13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/ijc.22322","article-title":"Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase","volume":"120","author":"Yoon","year":"2007","journal-title":"Int J Cancer"},{"key":"2025051308465598500_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1086\/409853","article-title":"The biological effects and mode of action of L-canavanine, a structural analogue of L-arginine","volume":"52","author":"Rosenthal","year":"1977","journal-title":"Q Rev Biol"},{"key":"2025051308465598500_bib15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/1475636031000152277","article-title":"The mechanism of L-canavanine cytotoxicity: arginyl tRNA synthetase as a novel target for anticancer drug discovery","volume":"18","author":"Bence","year":"2003","journal-title":"J Enzyme Inhib Med Chem"},{"key":"2025051308465598500_bib16","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V126.23.3005.3005","article-title":"Interfering with arginine metabolism as a new treatment strategy for multiple myeloma","volume":"126","author":"Jacobi","year":"2015","journal-title":"Blood"},{"key":"2025051308465598500_bib17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/1871520616666160223111551","article-title":"L-canavanine potentiates cytotoxicity of chemotherapeutic drugs in human breast cancer cells","volume":"17","author":"Nurcahyanti","year":"2017","journal-title":"Anticancer Agents Med Chem"},{"key":"2025051308465598500_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/A:1022435202066","article-title":"L-Canavanine as a radiosensitization agent for human pancreatic cancer cells","volume":"244","author":"Bence","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"2025051308465598500_bib19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1076\/phbi.36.3.194.6340","article-title":"L-canavanine: a potential chemotherapeutic agent for human pancreatic cancer","volume":"36","author":"Rosenthal","year":"1998","journal-title":"Pharm Biol"},{"key":"2025051308465598500_bib20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/jcp.41.6.623","article-title":"Quantification of oestrogen receptors in breast cancer: radiochemical assay on cytosols and cryostat sections compared with semiquantitative immunocytochemical analysis","volume":"41","author":"Scheres","year":"1988","journal-title":"J Clin Pathol"},{"key":"2025051308465598500_bib21","first-page":"A68","article-title":"The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge","volume":"19","author":"Tomczak","year":"2015","journal-title":"Contemp Oncol (Pozn)"},{"key":"2025051308465598500_bib22","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"2025051308465598500_bib23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/978-1-61779-080-5_34","article-title":"Analysis of drug interactions","volume":"731","author":"Bijnsdorp","year":"2011","journal-title":"Methods Mol Biol"},{"key":"2025051308465598500_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3360001","article-title":"Arginine metabolism: nitric oxide and beyond","volume":"336","author":"Wu","year":"1998","journal-title":"Biochem J"},{"key":"2025051308465598500_bib25","doi-asserted-by":"crossref","first-page":"10668","DOI":"10.3390\/ijms241310668","article-title":"Unlocking the potential of arginine deprivation therapy: recent breakthroughs and promising future for cancer treatment","volume":"24","author":"Chu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025051308465598500_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.canlet.2008.11.031","article-title":"Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest","volume":"277","author":"Lam","year":"2009","journal-title":"Cancer Lett"},{"key":"2025051308465598500_bib27","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1182\/blood-2009-12-258822","article-title":"Pegylated arginase I: a potential therapeutic approach in T-ALL","volume":"115","author":"Hernandez","year":"2010","journal-title":"Blood"},{"key":"2025051308465598500_bib28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0041-008X(87)90062-7","article-title":"Metabolism of L-[guanidinooxy-14C]canavanine in the rat","volume":"91","author":"Thomas","year":"1987","journal-title":"Toxicol Appl Pharmacol"},{"key":"2025051308465598500_bib29","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cellsig.2013.11.028","article-title":"The role of cell signalling in the crosstalk between autophagy and apoptosis","volume":"26","author":"Booth","year":"2014","journal-title":"Cell Signal"},{"key":"2025051308465598500_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-201x.2000.00646.x","article-title":"Biological effects of arginine metabolites","volume":"168","author":"Blantz","year":"2000","journal-title":"Acta Physiol Scand"},{"key":"2025051308465598500_bib31","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1038\/onc.2011.576","article-title":"Metabolic reprogramming of the tumor","volume":"31","author":"Ferreira","year":"2012","journal-title":"Oncogene"},{"key":"2025051308465598500_bib32","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1158\/2159-8290.CD-12-0345","article-title":"Cancer cell metabolism: one hallmark, many faces","volume":"2","author":"Cantor","year":"2012","journal-title":"Cancer Discov"},{"key":"2025051308465598500_bib33","first-page":"423","article-title":"A global view of the biochemical pathways involved in the regulation of the metabolism of cancer cells","volume":"1826","author":"Icard","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"2025051308465598500_bib34","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/00001813-200410000-00002","article-title":"Controlling cancer by restricting arginine availability\u2013arginine-catabolizing enzymes as anticancer agents","volume":"15","author":"Wheatley","year":"2004","journal-title":"Anticancer Drugs"},{"key":"2025051308465598500_bib35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/CAD.0b013e32833e0334","article-title":"Canavanine augments proapoptotic effects of arginine deprivation in cultured human cancer cells","volume":"22","author":"Vynnytska","year":"2011","journal-title":"Anticancer Drugs"},{"key":"2025051308465598500_bib36","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1158\/1535-7163.MCT-09-0794","article-title":"Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc\/HIF-1alpha\/Sp4","volume":"8","author":"Tsai","year":"2009","journal-title":"Mol Cancer Ther"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-24-0425\/3520404\/crc-24-0425.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/12\/3180\/3527133\/crc-24-0425.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/12\/3180\/3527133\/crc-24-0425.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T08:47:10Z","timestamp":1747126030000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/4\/12\/3180\/750649\/PEG-BCT-100-and-Canavanine-Synergistically-Induce"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-24-0425","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.29050104","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050116","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050110","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050113","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050101","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050095","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050098","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050119","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050107","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7815327","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,1]]}}}